Validity of new flow cytometric protocol in diagnosis of low-grade myelodysplastic syndromes
BJamoh Yusuf(Ahmadu Bello University Teaching Hospital), Sani Abubakar(Ahmadu Bello University), Abdullah A. Abba(Ahmadu Bello University Teaching Hospital), AG Bakari(Ahmadu Bello University Teaching Hospital), Khalid Ashfaq(National Institute for Health and Care Excellence), Paraskevi Goggolidou(Kingston University), Aminu Saidu(Federal Medical Centre), AI Dutse(Aminu Kano Teaching Hospital), BA Gwaram(Aminu Kano Teaching Hospital), Timothy Milne(King's College Hospital)
Cited by 0
Related Papers
Health Related Quality of Life of Stroke Survivors: Experience of a Stroke Unit
|International Journal of Biomedical Science|2012|122
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
|Haematologica|2016|100
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
|Leukemia & lymphoma/Leukemia and lymphoma|2012|69